virosome, virosom, virosomes, virosomal, Pevion Biotech, experts in vaccine design
Header

News

26.04.2010   Pevion announces excellent preclinical results for PEV4 RSV Vaccine candidate   News
22.03.2010   Pevion Biotech’s PEV7 Vulvovaginal Candidiasis Vaccine Enters Phase I   News
23.11.2009   Pevion Biotech appoints Dr. Christian A. Spyr to be Head of Project Management & Clinical Development   Archive
22.06.2009   Positive Phase I Trial Results for Pevion Biotech’s and Bio Life Science’s Breast Cancer Vaccine   Archive
19.05.2009   Pevion Biotech's board of directors elects new member    Archive
23.02.2009   Invitation to Pevion Biotech´s Open Day - March 14, 2009   Archive
12.01.2009   Pevion Biotech Appoints New CEO    Archive
22.12.2008   Generex Biotechnology and Pevion Biotech Ltd. announce plans for immunotherapeutic vaccine collaboration   Archive
18.07.2008   Pevion Biotech has moved to Ittigen   Archive
07.05.2008   Pevion Biotech signs Cooperation Agreement with ISS   Archive
25.10.2007   Pevion Biotech Winner of the Life Sciences Prize 2007   Archive
10.08.2007   Pevion Biotech secures CHF 35 Million in Series A financing round   Archive
09.08.2007   Pevion Biotech's board of directors elects new members   Archive
30.03.2007   EU Grant for Pevion Biotech's malaria vaccine   Archive
29.03.2007   Pevion Biotech and Mymetics enter license agreement   Archive
13.03.2007   Potentieller RSV Impfstoff der Ruhr-Universität Bochum erfolgreich an die Pevion Biotech Ltd. auslizenziert   Archive
18.12.2006   Hepatitis C vaccine enters clinical phase I   Archive
25.09.2006   Virosome-based breast cancer vaccine enters clinical development   Archive
06.04.2006   Dr. Jaap Goudsmit is new member to Board of Directors   Archive
07.03.2006   Positive final Phase I results for Pevion Biotech´s malaria vaccine   Archive
17.02.2005   Bio Life Science and Pevion Biotech enter collaboration to develop a breast cancer immunotherapeutic   Archive
18.06.2004   Pevion Biotech announces positive results in clinical phase I trial for its malaria vaccine   Archive
25.02.2004   Pevion Biotech and AlgoNomics establish collaboration for rational vaccine development   Archive
30.10.2003   Start Malaria Phase I   Archive
05.12.2002   Start-up Pevion Biotech Ltd   Archive
16.10.2001   Joint-venture of Bachem and Berna Biotech   Archive



 > CONTACT
Pevion Biotech Ltd.
Worblentalstrasse 32
3063 Ittigen / Bern
Schweiz
T +41 31 550 44 44
F +41 31 550 44 45
info@pevion.com